Jw. Gratama et al., Comparison of single and dual-platform assay formats for CD34(+) haematopoietic progenitor cell enumeration, CLIN LAB H, 21(5), 1999, pp. 337-346
Most techniques for CD34(+) cell enumeration are dual platform assays. That
is, they derive absolute numbers of CD34(+) cells from either the flow cyt
ometrically assessed per cent (%) CD34(+) cells within the nucleated cells
and/or the white blood cell count from a haematology cell analyser. Recentl
y, so-called single-platform assays have been developed, in which the absol
ute number of CD34(+) cells is directly derived from a single flow cytometr
ic measurement. The present study aims to compare the variation between eig
ht laboratories in CD34(+) cell counts from paired assays of 15 samples usi
ng a common single (ProCOUNT(TM)) and the local dual-platform method. Six l
aboratories used the 'SIHON' and two the 'ISHAGE' protocol for CD34(+) cell
enumeration.Use of the single-platform method reduced the inter-laboratory
variation in per cent and absolute numbers of CD34(+) cells, as measured b
y interquartile ranges, by half but did not lead to an appreciable reductio
n of the inter-laboratory variation in white blood cell counts. Thus, part
of the reduced inter-laboratory variation obtained with ProCOUNT(TM) may ha
ve been a result of the use of standardized procedures and reagents to dete
ct CD34(+) cells. In order to eliminate any variation arising from the use
of different local protocols for percentage of CD34(+) cell assessments, a
comparison was made of the ProCOUNT(TM)-derived absolute CD34(+) cell numbe
rs (i.e. single platform) with the dual-platform absolute CD34(+) cell numb
ers calculated by multiplying ProCOUNT(TM)-derived percentage of CD34(+) ce
lls and with the corresponding haematology analyser-derived white blood cel
l count. Regardless, the interquartile ranges of absolute CD34(+) cell numb
ers remained almost a factor of two smaller with the use of the single plat
form method. Thus, these results suggest that single-platform methodology c
an reduce the variation in absolute CD34(+) cell numbers between laboratori
es.